A Hybrid Protein-Oxygen Nanomedicine Overcomes Osimertinib Resistance in NSCLC via HIF-1α/VEGF/EGFR Inhibition
International Journal of Nanomedicine · 2025-08 · Volume 20 · 10389-10405
DOI: 10.2147/ijn.s531571 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025-08. Verfasst von Guanming Jiang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, Guangdong, 523059, People's Re…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Drug Resistance, Neoplasm, Aniline Compounds. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, Guangdong, 523059, People's Republic of China.
- Research Center of Nano Technology and Application Engineering, The First Dongguan Affiliated Hospital, School of Pharmacy, Guangdong Medical University, Dongguan, Guangdong, 523808, People's Republic of China.
- Dongguan Biomedical Nano Engineering Technology Research Center, Guangdong Medical University, Dongguan, Guangdong, 523808, People's Republic of China.
- Respiratory department, Tsinghua University Yuquan Hospital, Beijing, 100040, People's Republic of China.
- Department of Thoracic Surgery, Tenth Affiliated Hospital, Southern Medical University (Dongguan People's hospital), Dongguan, Guangdong, 523059, People's Republic of China.
Zitieren
APA
Jiang, G., Liu, X., Zhang, D., Diao, Z., Yang, X., Tan, Q., Chen, S., Zhang, W., Yin, X., Yin, T., Wang, X., & Zhou, J. (2025). A Hybrid Protein-Oxygen Nanomedicine Overcomes Osimertinib Resistance in NSCLC via HIF-1α/VEGF/EGFR Inhibition. International Journal of Nanomedicine, Volume 20, 10389-10405. https://doi.org/10.2147/ijn.s531571
Vancouver
Jiang G, Liu X, Zhang D, Diao Z, Yang X, Tan Q, et al. A Hybrid Protein-Oxygen Nanomedicine Overcomes Osimertinib Resistance in NSCLC via HIF-1α/VEGF/EGFR Inhibition. International Journal of Nanomedicine. 2025;Volume 20:10389-10405. doi:10.2147/ijn.s531571
BibTeX
@article{Jiang2025,
author = {Jiang, Guanming and Liu, Xuyi and Zhang, Dou and Diao, Zhenying and Yang, Xiaojun and Tan, Qinquan and Chen, Shiyuan and Zhang, Wan and Yin, Xiumao and Yin, Ting and Wang, Xiaozhen and Zhou, Jianping},
title = {A Hybrid Protein-Oxygen Nanomedicine Overcomes Osimertinib Resistance in NSCLC via HIF-1α/VEGF/EGFR Inhibition},
journal = {International Journal of Nanomedicine},
year = {2025},
volume = {Volume 20},
pages = {10389--10405},
doi = {10.2147/ijn.s531571}
}
EUVIMED